Cargando…
Serum Metabolic Profile in Multiple Sclerosis Patients
Multiple sclerosis (MS) is a progressive demyelinating process considered as an autoimmune disease, although the causes of this pathology have not been yet fully established. Similarly to other neurodegenerations, MS is characterized by a series of biochemical changes affecting to different extent n...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196932/ https://www.ncbi.nlm.nih.gov/pubmed/22096628 http://dx.doi.org/10.1155/2011/167156 |
_version_ | 1782214255428239360 |
---|---|
author | Tavazzi, Barbara Batocchi, Anna Paola Amorini, Angela Maria Nociti, Viviana D'Urso, Serafina Longo, Salvatore Gullotta, Stefano Picardi, Marika Lazzarino, Giuseppe |
author_facet | Tavazzi, Barbara Batocchi, Anna Paola Amorini, Angela Maria Nociti, Viviana D'Urso, Serafina Longo, Salvatore Gullotta, Stefano Picardi, Marika Lazzarino, Giuseppe |
author_sort | Tavazzi, Barbara |
collection | PubMed |
description | Multiple sclerosis (MS) is a progressive demyelinating process considered as an autoimmune disease, although the causes of this pathology have not been yet fully established. Similarly to other neurodegenerations, MS is characterized by a series of biochemical changes affecting to different extent neuronal functions; great attention has been given to oxidative/nitrosative stress and to alterations in mitochondrial functions. According to previous data, MS patients show significant changes in the circulating concentrations of different metabolites, although it is still unclear whether uric acid undergoes to decrease, increase, or no change under this pathological condition. In this study, we report the serum metabolic profile in terms of purines, pyrimidines, creatinine, malondialdehyde, ascorbic acid, nitrite, and nitrate in a group of 170 MS patients. The results show increase in circulating uric acid and other oxypurines (hypoxanthine and xanthine), as well as in uridine and β-pseudouridine. The concomitant increase in circulating creatinine, malondialdehyde, nitrite, and nitrate, and decrease in ascorbic acid, demonstrates that MS induces alteration in energy metabolism and in oxidants/antioxidants balance that can be monitored in serum of MS patients. |
format | Online Article Text |
id | pubmed-3196932 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-31969322011-11-17 Serum Metabolic Profile in Multiple Sclerosis Patients Tavazzi, Barbara Batocchi, Anna Paola Amorini, Angela Maria Nociti, Viviana D'Urso, Serafina Longo, Salvatore Gullotta, Stefano Picardi, Marika Lazzarino, Giuseppe Mult Scler Int Research Article Multiple sclerosis (MS) is a progressive demyelinating process considered as an autoimmune disease, although the causes of this pathology have not been yet fully established. Similarly to other neurodegenerations, MS is characterized by a series of biochemical changes affecting to different extent neuronal functions; great attention has been given to oxidative/nitrosative stress and to alterations in mitochondrial functions. According to previous data, MS patients show significant changes in the circulating concentrations of different metabolites, although it is still unclear whether uric acid undergoes to decrease, increase, or no change under this pathological condition. In this study, we report the serum metabolic profile in terms of purines, pyrimidines, creatinine, malondialdehyde, ascorbic acid, nitrite, and nitrate in a group of 170 MS patients. The results show increase in circulating uric acid and other oxypurines (hypoxanthine and xanthine), as well as in uridine and β-pseudouridine. The concomitant increase in circulating creatinine, malondialdehyde, nitrite, and nitrate, and decrease in ascorbic acid, demonstrates that MS induces alteration in energy metabolism and in oxidants/antioxidants balance that can be monitored in serum of MS patients. Hindawi Publishing Corporation 2011 2011-06-28 /pmc/articles/PMC3196932/ /pubmed/22096628 http://dx.doi.org/10.1155/2011/167156 Text en Copyright © 2011 Barbara Tavazzi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Tavazzi, Barbara Batocchi, Anna Paola Amorini, Angela Maria Nociti, Viviana D'Urso, Serafina Longo, Salvatore Gullotta, Stefano Picardi, Marika Lazzarino, Giuseppe Serum Metabolic Profile in Multiple Sclerosis Patients |
title | Serum Metabolic Profile in Multiple Sclerosis Patients |
title_full | Serum Metabolic Profile in Multiple Sclerosis Patients |
title_fullStr | Serum Metabolic Profile in Multiple Sclerosis Patients |
title_full_unstemmed | Serum Metabolic Profile in Multiple Sclerosis Patients |
title_short | Serum Metabolic Profile in Multiple Sclerosis Patients |
title_sort | serum metabolic profile in multiple sclerosis patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196932/ https://www.ncbi.nlm.nih.gov/pubmed/22096628 http://dx.doi.org/10.1155/2011/167156 |
work_keys_str_mv | AT tavazzibarbara serummetabolicprofileinmultiplesclerosispatients AT batocchiannapaola serummetabolicprofileinmultiplesclerosispatients AT amoriniangelamaria serummetabolicprofileinmultiplesclerosispatients AT nocitiviviana serummetabolicprofileinmultiplesclerosispatients AT dursoserafina serummetabolicprofileinmultiplesclerosispatients AT longosalvatore serummetabolicprofileinmultiplesclerosispatients AT gullottastefano serummetabolicprofileinmultiplesclerosispatients AT picardimarika serummetabolicprofileinmultiplesclerosispatients AT lazzarinogiuseppe serummetabolicprofileinmultiplesclerosispatients |